{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,3]],"date-time":"2022-04-03T07:07:50Z","timestamp":1648969670124},"reference-count":45,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2008,4,1]],"date-time":"2008-04-01T00:00:00Z","timestamp":1207008000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Heart Failure Clinics"],"published-print":{"date-parts":[[2008,4]]},"DOI":"10.1016\/j.hfc.2008.01.003","type":"journal-article","created":{"date-parts":[[2008,4,21]],"date-time":"2008-04-21T12:33:10Z","timestamp":1208781190000},"page":"171-176","source":"Crossref","is-referenced-by-count":0,"title":["Investigations of Statins in Heart Failure: Inflammatory Biomarkers and Hormones"],"prefix":"10.1016","volume":"4","author":[{"given":"Bobby V.","family":"Khan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanjay","family":"Rajagopalan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.hfc.2008.01.003_bib1","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S1071-9164(97)90022-1","article-title":"The effects of simvastatin on the incidence of heart failure in patients with coronary artery disease","volume":"3","author":"Kjekshus","year":"1997","journal-title":"J Card Fail"},{"key":"10.1016\/j.hfc.2008.01.003_bib2","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.jacc.2003.07.049","article-title":"Statin therapy is associated with improved survival in ischemic and non-ischemic heart failure","volume":"43","author":"Horwich","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hfc.2008.01.003_bib3","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.amjcard.2003.11.027","article-title":"Effect of combined statin and beta blocker treatment on one-year morbidity and mortality after acute myocardial\u00a0infarction associated with heart failure","volume":"93","author":"Hognestad","year":"2004","journal-title":"Am J\u00a0Cardiol"},{"key":"10.1016\/j.hfc.2008.01.003_bib4","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/j.amjcard.2004.01.039","article-title":"Statin therapy is associated with lower mortality among patients with severe heart failure","volume":"93","author":"Mozaffarian","year":"2004","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hfc.2008.01.003_bib5","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1161\/01.CIR.0000084539.58092.DE","article-title":"Short-term statin therapy improves cardiac function and symptoms in patients with idiopathic dilated cardiomyopathy","volume":"108","author":"Node","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.hfc.2008.01.003_bib6","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s00392-004-1005-0","article-title":"Beneficial effects of statins in patients with non-ischemic heart failure","volume":"93","author":"Laufs","year":"2004","journal-title":"Z Kardiol"},{"key":"10.1016\/j.hfc.2008.01.003_bib7","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.atherosclerosis.2004.08.037","article-title":"Effects of atorvastatin on reactive hyperemia and inflammatory process in patients with congestive heart failure","volume":"178","author":"Tousoulis","year":"2005","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.hfc.2008.01.003_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1056\/NEJMoa0706201","article-title":"Rosuvastatin in older patients with systolic heart failure","volume":"357","author":"Kjekshus","year":"2007","journal-title":"N Engl J\u00a0Med"},{"key":"10.1016\/j.hfc.2008.01.003_bib9","first-page":"S31","article-title":"Nonischemic heart failure: epidemiology, pathophysiology, and progression of disease","volume":"33","author":"Follath","year":"1999","journal-title":"J\u00a0Cardiovasc Pharmacol"},{"key":"10.1016\/j.hfc.2008.01.003_bib10","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1161\/01.RES.0000043825.01705.1B","article-title":"Inflammatory mediators and the failing heart: past, present, and the foreseeable future","volume":"91","author":"Mann","year":"2002","journal-title":"Circ Res"},{"key":"10.1016\/j.hfc.2008.01.003_bib11","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1007\/s00395-003-0433-8","article-title":"Tumor necrosis factor-alpha and the failing heart: pathophysiology and therapeutic implications","volume":"99","author":"von Huehling","year":"2004","journal-title":"Basic Res Cardiol"},{"key":"10.1016\/j.hfc.2008.01.003_bib12","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1016\/S0140-6736(96)07015-8","article-title":"Wasting as independent risk factor for mortality in chronic heart failure","volume":"349","author":"Anker","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.hfc.2008.01.003_bib13","doi-asserted-by":"crossref","first-page":"3060","DOI":"10.1161\/01.CIR.102.25.3060","article-title":"Plasma cytokine parameters and mortality in patients with heart failure","volume":"102","author":"Rauschhaus","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.hfc.2008.01.003_bib14","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1161\/01.CIR.103.16.2055","article-title":"Cytokines and cytokine receptors in advanced heart failure: an analysis of the cytokine database from the Vesnarinone Trial (VEST)","volume":"103","author":"Deswal","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.hfc.2008.01.003_bib15","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1159\/000006913","article-title":"C-reactive protein in dilated cardiomyopathy","volume":"91","author":"Kaneko","year":"1999","journal-title":"Cardiology"},{"key":"10.1016\/j.hfc.2008.01.003_bib16","doi-asserted-by":"crossref","first-page":"45","DOI":"10.4065\/77.1.45","article-title":"Autonomic tone as a cardiovascular risk factor: the dangers of chronic fight or flight","volume":"77","author":"Curtis","year":"2002","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.hfc.2008.01.003_bib17","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1161\/01.HYP.25.6.1276","article-title":"Spectral analysis of blood pressure and heart rate variability in evaluating cardiovascular regulation: a critical appraisal","volume":"25","author":"Parati","year":"1995","journal-title":"Hypertension"},{"key":"10.1016\/j.hfc.2008.01.003_bib18","first-page":"V15","article-title":"Mechanistic data from the VA cooperative studies: ejection fraction, peak exercise oxygen consumption, cardiothoracic ratio, ventricular arrhythmia, and plasma norepinephrine as determinants of prognosis in heart failure","volume":"86","author":"Cohn","year":"1993","journal-title":"Circulation"},{"key":"10.1016\/j.hfc.2008.01.003_bib19","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1161\/01.CIR.0000065606.63163.B9","article-title":"Simvastatin normalizes autonomic neural control in heart failure","volume":"107","author":"Pliquett","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.hfc.2008.01.003_bib20","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.jacc.2005.10.031","article-title":"The emerging role of statins in the treatment of heart failure","volume":"47","author":"Ramasubbu","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hfc.2008.01.003_bib21","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/S0008-6363(00)00146-2","article-title":"Effects of statins on vascular wall: vasomotor function, inflammation, and plaque stability","volume":"47","author":"Koh","year":"2000","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.hfc.2008.01.003_bib22","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1161\/01.CIR.0000033635.42612.88","article-title":"Statins as potent anti-inflammatory drugs","volume":"106","author":"Lefer","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.hfc.2008.01.003_bib23","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1161\/hc0702.104164","article-title":"Fluvastatin attenuates left ventricular remodeling and failure after myocardial infarction","volume":"105","author":"Hayashidani","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.hfc.2008.01.003_bib24","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1038\/nrd1901","article-title":"Anti-inflammatory effects of statins: clinical evidence and basic mechanisms","volume":"4","author":"Jain","year":"2005","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.hfc.2008.01.003_bib25","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1038\/ncpcardio0855","article-title":"Drug insight: statins for nonischemic heart failure. Evidence and potential mechanisms","volume":"4","author":"Lipinski","year":"2007","journal-title":"Nat Clin Pract Cardiovasc Med"},{"key":"10.1016\/j.hfc.2008.01.003_bib26","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1056\/NEJM200106283442601","article-title":"Air Force\/Texas Coronary Atherosclerosis Prevention Study Investigators: measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events","volume":"344","author":"Ridker","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hfc.2008.01.003_bib27","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1016\/j.jacc.2003.07.016","article-title":"The relationship between cholesterol and survival in patients with chronic heart failure","volume":"42","author":"Rauschhaus","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hfc.2008.01.003_bib28","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1159\/000006785","article-title":"Low serum cholesterol levels predict high perioperative mortality in patients supported by a left ventricular assist system","volume":"89","author":"Richartz","year":"1998","journal-title":"Cardiology"},{"key":"10.1016\/j.hfc.2008.01.003_bib29","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1054\/jcaf.2002.0804216","article-title":"Low serum total cholesterol is associated with marked increase in mortality in advanced heart failure","volume":"8","author":"Horwich","year":"2002","journal-title":"J Cardiac Failure"},{"key":"10.1016\/j.hfc.2008.01.003_bib30","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/S0140-6736(00)02690-8","article-title":"The endotoxin-lipoprotein hypothesis","volume":"356","author":"Rauschhaus","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.hfc.2008.01.003_bib31","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1054\/JCPT.2000.16695","article-title":"Effects of lovastatin and pravastatin on the survival of hamsters with inherited cardiomyopathy","volume":"5","author":"Marz","year":"2000","journal-title":"J Cardiovasc Pharmacol Ther"},{"key":"10.1016\/j.hfc.2008.01.003_bib32","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1067\/mhj.2001.116762","article-title":"The effect of pravastatin and atorvastatin on coenzyme Q10","volume":"142","author":"Bleske","year":"2001","journal-title":"Am Heart J"},{"key":"10.1016\/j.hfc.2008.01.003_bib33","doi-asserted-by":"crossref","first-page":"703","DOI":"10.2165\/00002018-200629080-00007","article-title":"Effect of ezetimibe and\/or simvastatin on coenzyme Q10 levels in plasma: a randomised trial","volume":"29","author":"Berthold","year":"2006","journal-title":"Drug Saf"},{"key":"10.1016\/j.hfc.2008.01.003_bib34","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.atherosclerosis.2004.10.009","article-title":"Endothelium-ameliorating effects of statin therapy and coenzyme Q10 reductions in chronic heart failure","volume":"179","author":"Strey","year":"2005","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.hfc.2008.01.003_bib35","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.cardfail.2006.03.007","article-title":"The impact of coenzyme Q10 on systolic function in patients with chronic heart failure","volume":"12","author":"Sander","year":"2006","journal-title":"J Card Fail"},{"key":"10.1016\/j.hfc.2008.01.003_bib36","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1161\/01.CIR.0000160924.73417.26","article-title":"Long-Term Intervention With Pravastatin in Ischemic Disease (LIPID) Study Investigators: white blood cell count predicts reduction in coronary heart disease mortality with pravastatin","volume":"111","author":"Stewart","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.hfc.2008.01.003_bib37","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/clc.4960290109","article-title":"Effect of statins and white blood cell count on mortality in patients with ischemic left ventricular dysfunction undergoing percutaneous coronary intervention","volume":"29","author":"Lipinski","year":"2006","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.hfc.2008.01.003_bib38","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.cardfail.2005.05.011","article-title":"Statin therapy is associated with improved cardiovascular outcomes and levels of inflammatory makers in patients with heart failure","volume":"11","author":"Sola","year":"2005","journal-title":"J Card Fail"},{"key":"10.1016\/j.hfc.2008.01.003_bib39","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.jacc.2005.06.088","article-title":"Atorvastatin improves left ventricular systolic function in nonischemic heart failure","volume":"47","author":"Sola","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hfc.2008.01.003_bib40","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/j.amjcard.2005.09.142","article-title":"Usefulness of atorvastatin in patients with heart failure due to inflammatory dilated cardiomyopathy and elevated cholesterol levels","volume":"97","author":"Wojnicz","year":"2006","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hfc.2008.01.003_bib41","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1097\/00001573-199905000-00004","article-title":"Insights into the pathogenesis of heart failure: immune activation and cachexia","volume":"14","author":"Anker","year":"1999","journal-title":"Curr Opin Cardiol"},{"key":"10.1016\/j.hfc.2008.01.003_bib42","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.jacc.2005.06.087","article-title":"Neutral effects of markers of heart failure, inflammation, endothelial activation and function, and vagal tone following HMG-CoA reductase inhibition in non-diabetic cardiomyopathy and average low-density lipoprotein level","volume":"47","author":"Bleske","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hfc.2008.01.003_bib43","first-page":"28","article-title":"Use of statins in heart failure","volume":"3","author":"Sosnowski","year":"2004","journal-title":"European Journal of Cardiology Practice"},{"key":"10.1016\/j.hfc.2008.01.003_bib44","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/j.ejheart.2005.09.005","article-title":"CORONA: controlled rosuvastatin multinational study in heart failure","volume":"7","author":"Kjekshus","year":"2005","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.hfc.2008.01.003_bib45","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.ejheart.2004.03.001","article-title":"Rationale and design of the GISSI heart failure trial: a large trial to assess the effects of n-3 polyunsaturated fatty acids and rosuvastatin in symptomatic congestive heart failure","volume":"6","author":"Tavazzi","year":"2004","journal-title":"Eur J Heart Fail"}],"container-title":["Heart Failure Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551713608000056?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551713608000056?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,29]],"date-time":"2018-12-29T17:52:25Z","timestamp":1546105945000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1551713608000056"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,4]]},"references-count":45,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008,4]]}},"alternative-id":["S1551713608000056"],"URL":"https:\/\/doi.org\/10.1016\/j.hfc.2008.01.003","relation":{},"ISSN":["1551-7136"],"issn-type":[{"value":"1551-7136","type":"print"}],"subject":[],"published":{"date-parts":[[2008,4]]}}}